NCMG
ABBV icon

NCM Capital Management Group’s AbbVie ABBV Stock Holding History

NCM Capital Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-32,700
Closed -$1.73M – 89
2013
Q4 		$1.73M Sell
32,700
-24,700
-43% -$1.21M 1.13% 39
2013
Q3 		$2.57M Hold
57,400
– – 1.85% 16
2013
Q2 		$2.37M Buy
+57,400
New +$2.51M 1.83% 19

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

NCM Capital Management Group's ABBV Position: Q1 2014 in Review

NCM Capital Management Group sold out of AbbVie (ABBV) in Q1 2014, closing a stake of 32,700 shares — an estimated $1.73M sold.

NCM Capital Management Group first reported a position in ABBV in Q2 2013 and held it in 3 quarters. The position peaked at $2.57M in Q3 2013. 1,422 funds tracked by Wall St. Rank hold ABBV as of Q1 2014.

  • NCM Capital Management Group reported no remaining AbbVie position as of Q1 2014 after selling out during the quarter.
  • NCM Capital Management Group sold 32,700 AbbVie shares in Q1 2014, an estimated $1.73M.
  • NCM Capital Management Group first reported a position in AbbVie in Q2 2013 and held it in 3 quarters.
  • NCM Capital Management Group's AbbVie position peaked at $2.57M in Q3 2013.
  • 1,422 funds tracked by Wall St. Rank held AbbVie as of Q1 2014.

Based on NCM Capital Management Group's 13F filing for Q1 2014, filed 6 May 2014.